Bionomics Ltd
(NASDAQ: BNOX)
|
5:30 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $0.67 | Change: -0.04 | %Change: -5.85% | Volume: 50,035 |
Open: | $ 0.73 | Volume: | 50,035 | |
---|---|---|---|---|
High: | $ 0.73 | Yield(%) | 0.00 | |
Low: | $ 0.65 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 7.59M | |
EPS ($) | n/a | Shares Out: | 10.69M |
% Price Change (last 4 weeks): | 1.07 |
---|---|
% Price Change (last 13 weeks): | -28.56 |
% Price Change (last 26 weeks): | -47.59 |
% Price Change (last 52 weeks): | -69.65 |
% Price Change (year to date): | -52.03 |
Return on Equity (%): | -70.00 |
---|---|
Return on Assets (%): | -58.26 |
Return on Invested Capital (%): | -40.50 |
Gross Profit Margin (%): | n/a |
---|---|
Net Profit Margin (%): | -144450.30 |
Operating Profit Margin (%): | -147875.51 |
50-day Moving Average: | $0.87 |
---|---|
200-day Moving Average: | $1.46 |
Avg. Daily Vol. (last 50 days): | 201,100 |
Avg. Daily Vol. (last 200 days): | 1,270,490 |
52-wk high: | $6.41 |
52-wk low: | $0.65 |
Bid: | $0.67 |
Ask: | $0.71 |
Bionomics Ltd. is a clinical stage biopharmaceutical company. It engages in the development of novel drug candidates focused on the treatment of serious central nervous system disorders. Its lead product candidate is BNC210. The company was founded in 1996 and is headquartered in Eastwood, Australia.
|
Bionomics Ltd
200 Greenhill Road Eastwood SA 5063 Phone: 61.8.8150.7400 Fax: n/a http://www.bionomics.com.au |
Earnings (1year) ($): | -2.35 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 2.70 |
Cash Flow ($): | -2.53 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 1210.48 |
Price/Book (x): | 0.81 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 4.87 |
---|---|
Current Ratio (x): | 4.87 |
LT Debt/Equity (x): | 1.09 |
Total Debt/Equity (x): | 1.61 |